GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gensight Biologics SIGHT.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.08

+11.85%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Gensight Biologics

Our reporting

We have not reported on Gensight Biologics yet.

Next results

19 Mar 2027

Due on 19 Mar 2027.

Past results

Reported against what analysts expected

29 Sept 202627 Mar 202619 Sept 202524 Oct 202426 Mar 202415 Sept 2023
Earnings per share-0.05-0.03-0.05-0.07-0.07-0.26
Revenue−€856,000−€47,000−€200,000€1.1m€1.1m€1.6m
Forecast−€40,570−€47,000€49,072€1.5m€4.5m€4.5m

Key events

  1. 13 Jul 2016Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.